Document resource
Tiffany E Jiang, Reshma Ramachandran, and Joshua J Skydel argue that US requirements for interchangeability are not supported by evidence and hamper use of biosimilars
Annotated abstract
Regulatory change could improve biosimilar access in the US
bmj · 2025-07-29 · canonical JSON source